After his diagnosis with a rare, incurable blood cancer, Jack Whelan began his journey on the road to personalized medicine, a road still under construction. His encounters on an often-bumpy road, filled with regulatory roadblocks, relapsed/refractory detours and conflicting signals and biomarkers led him to a different path. Now, using his business communications and research skills from his career as a Wall Street research analyst in information technology, Whelan helps bridge the communications gap between life sciences, medical professionals and patients as a patient advocate, research advocate and legislative Advocate